Studer A, de Tribolet N, Diserens A C, Gaide A C, Matthieu J M, Carrel S, Stavrou D
Acta Neuropathol. 1985;66(3):208-17. doi: 10.1007/BF00688585.
In this paper, the characterization of four human malignant glioma cell lines is described. The four lines are positive for glial fibrillary acidic protein (GFAP) in variable amounts. One of them, LN 992, is positive for S-100 protein. Myelin basic protein could not be detected in any of the four lines. The four lines had high levels of CNPase activity. The karyotype shows polyploidy for all lines, with modal numbers ranging from 80 to 120 and various numbers of marker chromosomes. Particular attention has been paid to the surface phenotype and a panel of three antiglioma monoclonal antibodies (Mabs), five antimelanoma Mabs, one anti-CALLA Mab, and two anti-HLA-DR Mabs has been used in an antibody-binding radioimmunoassay for the four cell lines. Lines LN 215 and LN 235 are positive with two antiglioma Mabs, LN 992 is negative. The four lines are positive with all five antimelanoma Mabs, except for LN 992 which ist negative with Mab D5. LN 992 and LN 215 are positive with the anti-CALLA Mab N2A12. LN 308 and LN 992 are positive with anti-HLA-DR Mab D4-22. There was no correlation between the in vitro morphology of the lines and the expression of the various biochemical or surface markers. These results stress the heterogeneity of the phenotype of human malignant glioma lines. These lines will be useful tools for further immunologic studies.
本文描述了四种人类恶性胶质瘤细胞系的特征。这四种细胞系胶质纤维酸性蛋白(GFAP)呈不同程度阳性。其中之一,LN 992,S-100蛋白呈阳性。在这四种细胞系中均未检测到髓鞘碱性蛋白。这四种细胞系具有高水平的2',3'-环核苷酸3'-磷酸二酯酶(CNPase)活性。核型显示所有细胞系均为多倍体,众数范围为80至120,并有各种数量的标记染色体。已特别关注表面表型,并使用一组三种抗胶质瘤单克隆抗体(Mab)、五种抗黑色素瘤Mab、一种抗CALLA Mab和两种抗HLA-DR Mab对这四种细胞系进行抗体结合放射免疫分析。细胞系LN 215和LN 235与两种抗胶质瘤Mab呈阳性反应,LN 992为阴性。除LN 992与Mab D5呈阴性反应外,这四种细胞系与所有五种抗黑色素瘤Mab均呈阳性反应。LN 992和LN 215与抗CALLA Mab N2A12呈阳性反应。LN 308和LN 992与抗HLA-DR Mab D4-22呈阳性反应。细胞系的体外形态与各种生化或表面标志物的表达之间无相关性。这些结果强调了人类恶性胶质瘤细胞系表型的异质性。这些细胞系将是进一步免疫研究的有用工具。